- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Survivors of Pediatric Cancer May Have Increased Risk of Obesity, Study Finds
The study, published in Cancer, found a 14% higher rate of obesity among childhood cancer survivors in their surveyed population, compared to the federal numbers.
Childhood cancer survivors - especially those whose treatment included brain irradiation or chemotherapy with glucocorticoids - are 14% more likely to be obese than their healthy peers. The St. Jude Children's Research Hospital study appears today in the journal Cancer.
Of the 1996 childhood cancer survivors in this study, 36.2% had a body mass index (BMI) of 30 kilograms per meters squared or more, which qualifies as obese. That was 14% greater than the expected prevalence based on federal health survey data of a comparison group of US residents. Among the strongest predictor of obesity in survivors was childhood obesity, which is also a strong predictor of adult obesity in the general public. Survivors who were obese when their pediatric cancer was discovered were almost 5 times more likely than other survivors to be obese when their BMI was calculated for this study.
Complete report on MedicalXpress: http://bit.ly/1JTe3ge
Understanding the Unmet Need for Therapies to Treat Rare Bile Duct Cancer
May 24th 2022On this episode of Managed Care Cast, we bring you an excerpt of an interview with a co-chair of the 2022 Cholangiocarcinoma Foundation (CCF) annual conference, held earlier this year, about the significant unmet therapy needs facing most patients with this rare cancer.
Listen
Bimekizumab-bkzx, the Newest Psoriasis Treatment, Is Now Available
November 30th 2023Bimekizumab-bkzx (Bimzelx) is the first dual interleukin 17A (IL-17A) and interleukin 17F (IL-17F) inhibitor to treat moderate-to-severe plaque psoriasis. It launches with a list price of $7200 per syringe.
Read More
Study Finds ASCT Similarly Safe, Effective in Older and Younger Patients With Multiple Myeloma
November 30th 2023A real-world study suggests high-dose chemotherapy followed by autologous stem cell transplantation (ASCT) is feasible for appropriately selected elderly patients, with similar results seen in older and younger patients.
Read More
